Literature DB >> 3001641

Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNAs.

C R King, M H Kraus, L T Williams, G T Merlino, I H Pastan, S A Aaronson.   

Abstract

A survey of human tumor cell lines for increased PDGF or EGF receptors identified 5 lines which bind from 6 to 13 times more EGF than normal human fibroblasts. Immunoprecipitation analysis links the elevated binding activity to increased quantities of the EGF receptor protein. EGF receptor gene amplification was detected in 2 of the cell lines. No evidence for EGF receptor gene rearrangements was found at the level of DNA or RNA structure. The results suggest that elevated levels of EGF receptor can be associated with at least three distinct mechanisms. These include gene amplification accompanied by rearrangement, gene amplification without accompanied alteration of mRNA transcripts, and extensive expression without gene amplification.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001641      PMCID: PMC322146          DOI: 10.1093/nar/13.23.8477

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

3.  Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate.

Authors:  G M Wahl; M Stern; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Mechanism of activation of a human oncogene.

Authors:  C J Tabin; S M Bradley; C I Bargmann; R A Weinberg; A G Papageorge; E M Scolnick; R Dhar; D R Lowy; E H Chang
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

5.  Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.

Authors:  Y Yuasa; S K Srivastava; C Y Dunn; J S Rhim; E P Reddy; S A Aaronson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

6.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.

Authors:  E P Reddy; R K Reynolds; E Santos; M Barbacid
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

7.  Elevated epidermal growth factor receptor gene copy number and expression in a squamous carcinoma cell line.

Authors:  G T Merlino; Y H Xu; N Richert; A J Clark; S Ishii; S Banks-Schlegel; I Pastan
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

8.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.

Authors:  M Schwab; K Alitalo; K H Klempnauer; H E Varmus; J M Bishop; F Gilbert; G Brodeur; M Goldstein; J Trent
Journal:  Nature       Date:  1983 Sep 15-21       Impact factor: 49.962

9.  Transposition and amplification of oncogene-related sequences in human neuroblastomas.

Authors:  N E Kohl; N Kanda; R R Schreck; G Bruns; S A Latt; F Gilbert; F W Alt
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

10.  A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells.

Authors:  M Schwab; K Alitalo; H E Varmus; J M Bishop; D George
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

View more
  23 in total

1.  Modulation of epidermal growth factor receptor proto-oncogene transcription by a promoter site sensitive to S1 nuclease.

Authors:  A C Johnson; Y Jinno; G T Merlino
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

2.  Identification of a novel AU-Rich element in the 3' untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins.

Authors:  L A Balmer; D J Beveridge; J A Jazayeri; A M Thomson; C E Walker; P J Leedman
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  The occurrence of epidermal growth factor receptors and the characterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancer. EGF receptors and factors in gynecological carcinomas.

Authors:  T Bauknecht; M Kohler; I Janz; A Pfleiderer
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

Review 4.  EGFR signaling and autophagy dependence for growth, survival, and therapy resistance.

Authors:  Barry Jutten; Kasper M A Rouschop
Journal:  Cell Cycle       Date:  2013-12-13       Impact factor: 4.534

5.  Chromatin structure of the EGFR gene suggests a role for intron 1 sequences in its regulation in breast cancer cells.

Authors:  S A Chrysogelos
Journal:  Nucleic Acids Res       Date:  1993-12-11       Impact factor: 16.971

6.  Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor.

Authors:  R N Jorissen; V C Epa; H R Treutlein; T P Garrett; C W Ward; A W Burgess
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

7.  Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.

Authors:  M H Kraus; P Fedi; V Starks; R Muraro; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

8.  The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor.

Authors:  W E Miller; H S Earp; N Raab-Traub
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene.

Authors:  M van de Vijver; R van de Bersselaar; P Devilee; C Cornelisse; J Peterse; R Nusse
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

Review 10.  EGF receptor expression, regulation, and function in breast cancer.

Authors:  S A Chrysogelos; R B Dickson
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.